Psychologists in Skillman, NJ Accepting Medicare
8 Psychologists found. Showing 1 - 8
 Mr. Jason A. Gold, PH.D - LCSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 43 Tamarack Cir, Skillman, NJ 08558 Phone: 609-356-0034 Fax: 609-356-0034 |
Dr. Allen Paul Blasucci, PSY.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 43 Tamarack Cir, Skillman, NJ 08558 Phone: 609-924-8010 Fax: 609-688-0045 |
 Dr. Laura Gwen Kogan, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 98 Tamarack Cir, Skillman, NJ 08558 Phone: 609-688-1244 |
Dr. Mark Kitzie, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 154 Tamarack Cir, Skillman, NJ 08558 Phone: 609-430-2121 Fax: 609-430-2121 |
Mr. Bruce E Reim, MSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 204 Hollow Road, Skillman, NJ 08558 Phone: 609-466-0166 Fax: 609-466-0166 |
Dr. Clifford Neil Lazarus, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 98 Tamarack Cir, Skillman, NJ 08558 Phone: 609-683-9122 Fax: 609-683-5229 |
Dr. Jody Kashden, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 165 Spring Hill Rd, Skillman, NJ 08558 Phone: 609-651-1863 |
Dr. Julia Van Pelt, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 10 Vreeland Dr, Suite 103, Skillman, NJ 08558 Phone: 732-993-7991 |
News Archive
FDA advisory committee recommends approval of Tolvaptan for hyponatremia
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
Study shows how bioactive component in soy foods plays a role against colon cancer
University of Illinois scientists have evidence that lifelong exposure to genistein, a bioactive component in soy foods, protects against colon cancer by repressing a signal that leads to accelerated growth of cells, polyps, and eventually malignant tumors.
Researchers focus on optimal use of immune agents in frontline setting for NSCLC treatment
Immunotherapy continues to revolutionize the field of non-small cell lung cancer (NSCLC), with researchers now focusing on the optimal use of immune agents in the frontline setting.
New drug helps children and young adults who have severe pain from sickle cell disease
Saint Louis University researchers are studying whether ReoPro® (abciximab), a drug currently given to heart patients undergoing angioplasties to open blocked arteries, also could help children and young adults who have severe pain from sickle cell disease.
› Verified 2 days ago
Clinical Social Workers
Counselors
Dentists
Psychologists
Pharmacists
Occupational Therapists